Design, synthesis, and biological evaluations of novel 3-amino-4-ethynyl indazole derivatives as Bcr-Abl kinase inhibitors with potent cellular antileukemic activity
AK El-Damasy, H Jin, SH Seo, EK Bang… - European Journal of …, 2020 - Elsevier
Abstract Breakpoint cluster region-Abelson (Bcr-Abl) kinase is a key driver in the
pathophysiology of chronic myelogenous leukemia (CML). Broadening the chemical …
pathophysiology of chronic myelogenous leukemia (CML). Broadening the chemical …
Design, synthesis, and biological evaluations of novel 3-amino-4-ethynyl indazole derivatives as Bcr-Abl kinase inhibitors with potent cellular antileukemic activity
AK El-Damasy, H Jin, SH Seo… - European journal of …, 2020 - pubmed.ncbi.nlm.nih.gov
Breakpoint cluster region-Abelson (Bcr-Abl) kinase is a key driver in the pathophysiology of
chronic myelogenous leukemia (CML). Broadening the chemical diversity of Bcr-Abl kinase …
chronic myelogenous leukemia (CML). Broadening the chemical diversity of Bcr-Abl kinase …
Design, synthesis, and biological evaluations of novel 3-amino-4-ethynyl indazole derivatives as Bcr-Abl kinase inhibitors with potent cellular antileukemic activity.
AK El-Damasy, H Jin, SH Seo, EK Bang… - European Journal of …, 2020 - europepmc.org
Breakpoint cluster region-Abelson (Bcr-Abl) kinase is a key driver in the pathophysiology of
chronic myelogenous leukemia (CML). Broadening the chemical diversity of Bcr-Abl kinase …
chronic myelogenous leukemia (CML). Broadening the chemical diversity of Bcr-Abl kinase …